Cargando…
A Preliminary Computational Investigation Into the Flow of PEG in Rat Myocardial Tissue for Regenerative Therapy
Myocardial infarction (MI), a type of cardiovascular disease, affects a significant proportion of people around the world. Traditionally, non-communicable chronic diseases were largely associated with aging populations in higher income countries. It is now evident that low- to middle-income countrie...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692440/ https://www.ncbi.nlm.nih.gov/pubmed/31448288 http://dx.doi.org/10.3389/fcvm.2019.00104 |
_version_ | 1783443553062486016 |
---|---|
author | Ngoepe, Malebogo Passos, Andreas Balabani, Stavroula King, Jesse Lynn, Anastasia Moodley, Jasanth Swanson, Liam Bezuidenhout, Deon Davies, Neil H. Franz, Thomas |
author_facet | Ngoepe, Malebogo Passos, Andreas Balabani, Stavroula King, Jesse Lynn, Anastasia Moodley, Jasanth Swanson, Liam Bezuidenhout, Deon Davies, Neil H. Franz, Thomas |
author_sort | Ngoepe, Malebogo |
collection | PubMed |
description | Myocardial infarction (MI), a type of cardiovascular disease, affects a significant proportion of people around the world. Traditionally, non-communicable chronic diseases were largely associated with aging populations in higher income countries. It is now evident that low- to middle-income countries are also affected and in these settings, younger individuals are at high risk. Currently, interventions for MI prolong the time to heart failure. Regenerative medicine and stem cell therapy have the potential to mitigate the effects of MI and to significantly improve the quality of life for patients. The main drawback with these therapies is that many of the injected cells are lost due to the vigorous motion of the heart. Great effort has been directed toward the development of scaffolds which can be injected alongside stem cells, in an attempt to improve retention and cell engraftment. In some cases, the scaffold alone has been seen to improve heart function. This study focuses on a synthetic polyethylene glycol (PEG) based hydrogel which is injected into the heart to improve left ventricular function following MI. Many studies in literature characterize PEG as a Newtonian fluid within a specified shear rate range, on the macroscale. The aim of the study is to characterize the flow of a 20 kDa PEG on the microscale, where the behavior is likely to deviate from macroscale flow patterns. Micro particle image velocimetry (μPIV) is used to observe flow behavior in microchannels, representing the gaps in myocardial tissue. The fluid exhibits non-Newtonian, shear-thinning behavior at this scale. Idealized two-dimensional computational fluid dynamics (CFD) models of PEG flow in microchannels are then developed and validated using the μPIV study. The validated computational model is applied to a realistic, microscopy-derived myocardial tissue model. From the realistic tissue reconstruction, it is evident that the myocardial flow region plays an important role in the distribution of PEG, and therefore, in the retention of material. |
format | Online Article Text |
id | pubmed-6692440 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-66924402019-08-23 A Preliminary Computational Investigation Into the Flow of PEG in Rat Myocardial Tissue for Regenerative Therapy Ngoepe, Malebogo Passos, Andreas Balabani, Stavroula King, Jesse Lynn, Anastasia Moodley, Jasanth Swanson, Liam Bezuidenhout, Deon Davies, Neil H. Franz, Thomas Front Cardiovasc Med Cardiovascular Medicine Myocardial infarction (MI), a type of cardiovascular disease, affects a significant proportion of people around the world. Traditionally, non-communicable chronic diseases were largely associated with aging populations in higher income countries. It is now evident that low- to middle-income countries are also affected and in these settings, younger individuals are at high risk. Currently, interventions for MI prolong the time to heart failure. Regenerative medicine and stem cell therapy have the potential to mitigate the effects of MI and to significantly improve the quality of life for patients. The main drawback with these therapies is that many of the injected cells are lost due to the vigorous motion of the heart. Great effort has been directed toward the development of scaffolds which can be injected alongside stem cells, in an attempt to improve retention and cell engraftment. In some cases, the scaffold alone has been seen to improve heart function. This study focuses on a synthetic polyethylene glycol (PEG) based hydrogel which is injected into the heart to improve left ventricular function following MI. Many studies in literature characterize PEG as a Newtonian fluid within a specified shear rate range, on the macroscale. The aim of the study is to characterize the flow of a 20 kDa PEG on the microscale, where the behavior is likely to deviate from macroscale flow patterns. Micro particle image velocimetry (μPIV) is used to observe flow behavior in microchannels, representing the gaps in myocardial tissue. The fluid exhibits non-Newtonian, shear-thinning behavior at this scale. Idealized two-dimensional computational fluid dynamics (CFD) models of PEG flow in microchannels are then developed and validated using the μPIV study. The validated computational model is applied to a realistic, microscopy-derived myocardial tissue model. From the realistic tissue reconstruction, it is evident that the myocardial flow region plays an important role in the distribution of PEG, and therefore, in the retention of material. Frontiers Media S.A. 2019-08-07 /pmc/articles/PMC6692440/ /pubmed/31448288 http://dx.doi.org/10.3389/fcvm.2019.00104 Text en Copyright © 2019 Ngoepe, Passos, Balabani, King, Lynn, Moodley, Swanson, Bezuidenhout, Davies and Franz. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Ngoepe, Malebogo Passos, Andreas Balabani, Stavroula King, Jesse Lynn, Anastasia Moodley, Jasanth Swanson, Liam Bezuidenhout, Deon Davies, Neil H. Franz, Thomas A Preliminary Computational Investigation Into the Flow of PEG in Rat Myocardial Tissue for Regenerative Therapy |
title | A Preliminary Computational Investigation Into the Flow of PEG in Rat Myocardial Tissue for Regenerative Therapy |
title_full | A Preliminary Computational Investigation Into the Flow of PEG in Rat Myocardial Tissue for Regenerative Therapy |
title_fullStr | A Preliminary Computational Investigation Into the Flow of PEG in Rat Myocardial Tissue for Regenerative Therapy |
title_full_unstemmed | A Preliminary Computational Investigation Into the Flow of PEG in Rat Myocardial Tissue for Regenerative Therapy |
title_short | A Preliminary Computational Investigation Into the Flow of PEG in Rat Myocardial Tissue for Regenerative Therapy |
title_sort | preliminary computational investigation into the flow of peg in rat myocardial tissue for regenerative therapy |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692440/ https://www.ncbi.nlm.nih.gov/pubmed/31448288 http://dx.doi.org/10.3389/fcvm.2019.00104 |
work_keys_str_mv | AT ngoepemalebogo apreliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy AT passosandreas apreliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy AT balabanistavroula apreliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy AT kingjesse apreliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy AT lynnanastasia apreliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy AT moodleyjasanth apreliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy AT swansonliam apreliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy AT bezuidenhoutdeon apreliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy AT daviesneilh apreliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy AT franzthomas apreliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy AT ngoepemalebogo preliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy AT passosandreas preliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy AT balabanistavroula preliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy AT kingjesse preliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy AT lynnanastasia preliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy AT moodleyjasanth preliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy AT swansonliam preliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy AT bezuidenhoutdeon preliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy AT daviesneilh preliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy AT franzthomas preliminarycomputationalinvestigationintotheflowofpeginratmyocardialtissueforregenerativetherapy |